Kang Le

734 total citations
32 papers, 498 citations indexed

About

Kang Le is a scholar working on Molecular Biology, Genetics and Physiology. According to data from OpenAlex, Kang Le has authored 32 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Genetics and 7 papers in Physiology. Recurrent topics in Kang Le's work include Hemoglobinopathies and Related Disorders (7 papers), Erythrocyte Function and Pathophysiology (4 papers) and Cancer-related molecular mechanisms research (3 papers). Kang Le is often cited by papers focused on Hemoglobinopathies and Related Disorders (7 papers), Erythrocyte Function and Pathophysiology (4 papers) and Cancer-related molecular mechanisms research (3 papers). Kang Le collaborates with scholars based in United States, China and Italy. Kang Le's co-authors include Mamta Gupta, Peiqing Liu, Joel Moss, Martha Vaughan, Chun-Chun Li, Fangyan Zhang, Shaorui Chen, Liang Tao, Zhaohe Wang and Yingnan Cao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Scientific Reports.

In The Last Decade

Kang Le

29 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kang Le United States 14 265 91 86 60 53 32 498
Dai Yuan China 14 250 0.9× 79 0.9× 70 0.8× 77 1.3× 38 0.7× 50 543
Yingqing Huo China 11 269 1.0× 52 0.6× 37 0.4× 80 1.3× 88 1.7× 15 506
Qinghui Xiong China 10 249 0.9× 83 0.9× 123 1.4× 79 1.3× 28 0.5× 17 539
Tongtong Xu China 13 358 1.4× 61 0.7× 159 1.8× 32 0.5× 40 0.8× 21 582
He Dong China 14 288 1.1× 86 0.9× 71 0.8× 36 0.6× 18 0.3× 29 549
Shee‐Ping Chen Taiwan 12 242 0.9× 44 0.5× 74 0.9× 87 1.4× 67 1.3× 16 577
Keyvan Yousefi United States 14 227 0.9× 78 0.9× 45 0.5× 31 0.5× 33 0.6× 26 519
Yan-ting Gu China 13 200 0.8× 53 0.6× 61 0.7× 29 0.5× 45 0.8× 26 463
Er‐shun Liang China 15 254 1.0× 62 0.7× 62 0.7× 77 1.3× 63 1.2× 21 540
Bong Jun Cho South Korea 14 324 1.2× 37 0.4× 106 1.2× 36 0.6× 41 0.8× 19 610

Countries citing papers authored by Kang Le

Since Specialization
Citations

This map shows the geographic impact of Kang Le's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kang Le with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kang Le more than expected).

Fields of papers citing papers by Kang Le

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kang Le. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kang Le. The network helps show where Kang Le may publish in the future.

Co-authorship network of co-authors of Kang Le

This figure shows the co-authorship network connecting the top 25 collaborators of Kang Le. A scholar is included among the top collaborators of Kang Le based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kang Le. Kang Le is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Conrey, Anna, Ingrid Frey, Julia Xu, et al.. (2025). Long-term mitapivat treatment is safe and efficacious in patients with sickle cell disease. PubMed. 1(2). 100014–100014.
3.
Le, Kang, Suzhen Lin, Shanshan Bao, & Junkui Mao. (2025). Modeling and analysis of performance degradation in proton exchange membrane fuel cell system for aviation applications. Aerospace Science and Technology. 162. 110236–110236.
4.
Le, Kang, Xunde Wang, Yuan Yee Lee, et al.. (2024). Activating pyruvate kinase improves red blood cell integrity by reducing band 3 tyrosine phosphorylation. Blood Advances. 8(21). 5653–5662. 3 indexed citations
5.
Le, Kang, Zenaide Quezado, Haiou Li, et al.. (2024). 8-Oxoguanine DNA Glycosylase 1 Recruits Transcription Factor STAT1 to Promote the Inflammatory Responses in Sickle Cell Disease. Blood. 144(Supplement 1). 2490–2490. 1 indexed citations
6.
D’Alessandro, Angelo, Kang Le, Quan Li, et al.. (2024). Functional and multi-omics signatures of mitapivat efficacy upon activation of pyruvate kinase in red blood cells from patients with sickle cell disease. Haematologica. 109(8). 2639–2652. 5 indexed citations
7.
Le, Kang, et al.. (2023). Anticancer mechanisms on pyroptosis induced by Oridonin: New potential targeted therapeutic strategies. Biomedicine & Pharmacotherapy. 165. 115019–115019. 13 indexed citations
8.
Le, Kang, et al.. (2023). SENP1 knockdown-mediated CTCF SUMOylation enhanced its stability and alleviated lipopolysaccharide-evoked inflammatory injury in human lung fibroblasts via regulation of FOXA2 transcription. Biochimica et Biophysica Acta (BBA) - General Subjects. 1868(1). 130500–130500. 3 indexed citations
9.
Le, Kang, et al.. (2023). Blockade of CCR1 induces a phenotypic shift in macrophages and triggers a favorable antilymphoma activity. Blood Advances. 7(15). 3952–3967. 16 indexed citations
10.
Le, Kang, Jingjing Han, Mary Stenson, et al.. (2023). Dependence of peripheral T‐cell lymphoma on constitutively activated JAK3: Implication for JAK3 inhibition as a therapeutic approach. Hematological Oncology. 42(1). e3233–e3233. 1 indexed citations
11.
Qaed, Eskandar, Yuelin Zhu, Yizhen Wang, et al.. (2023). Research Progress and New Perspectives of Anticancer Effects of Emodin. The American Journal of Chinese Medicine. 51(7). 1751–1793. 10 indexed citations
13.
Le, Kang, Jing Ping Sun, Maho Shibata, et al.. (2021). Mantle cell lymphoma polarizes tumor-associated macrophages into M2-like macrophages, which in turn promote tumorigenesis. Blood Advances. 5(14). 2863–2878. 25 indexed citations
15.
Le, Kang, et al.. (2021). CCR8 Signaling via CCL1 Regulates Responses of Intestinal IFN-γ Producing Innate Lymphoid CelIs and Protects From Experimental Colitis. Frontiers in Immunology. 11. 609400–609400. 6 indexed citations
16.
17.
Zou, Jian, Kang Le, Suowen Xu, et al.. (2013). Fenofibrate ameliorates cardiac hypertrophy by activation of peroxisome proliferator-activated receptor-α partly via preventing p65-NFκB binding to NFATc4. Molecular and Cellular Endocrinology. 370(1-2). 103–112. 43 indexed citations
18.
Le, Kang, Ruifang Li, Suowen Xu, et al.. (2011). PPARα activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4. Archives of Biochemistry and Biophysics. 518(1). 71–78. 29 indexed citations
20.
Cheng, Zhongping, Weihong Yang, Hong Dai, et al.. (2008). Laparoscopic Uterine Artery Occlusion Combined with Myomectomy for Uterine Myomas. Journal of Minimally Invasive Gynecology. 15(3). 346–349. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026